A Compassionate Use Trial With Bicalutamide (Casodex) 150-mg for Subjects With Prostate Cancer

AstraZeneca0 个研究点开始时间: 2008年3月14日最近更新: 2008年6月11日

适应症

试验速览

阶段: 不适用
状态: No Longer Available
发起方: AstraZeneca

研究概览入排标准研究者记录与标识符相似试验

研究概览

简要总结

This study provides compassionate use of bicalutamide (Casodex) at a 150-mg dose for subjects with prostate cancer prior to it becoming commercially available. The patient will receive bicalutamide 150-mg as long as the physician feels that the subject is benefiting from this therapy and safety information is provided regularly to AstraZeneca. Treatment will be discontinued after bicalutamide 150-mg becomes commercially available.

研究设计

研究类型: Expanded Access

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: Male
接受健康志愿者: 否

入选标准

•Patients with adenocarcinoma of the prostate
•Subjects with locally advanced, and/or metastatic prostate cancer for whom surgical castration or other medical interventions are not considered appropriate or acceptable

排除标准

•Any known history of abnormal liver function tests
•Any severe concomitant condition that would make it undesirable, in the clinician's opinion, for the subject to participate in the trial.
•Known hypersensitivity to bicalutamide or any of the components found in bicalutamide

研究者

发起方

AstraZeneca

申办方类型

Industry

相似试验

已完成

2 期

Efficacy and Safety of Zactima™ in Patients With Castration-refractory Metastatic Prostate CancerProstate Cancer

NCT00659438Genzyme, a Sanofi Company95

已完成

2 期

Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]Puberty, Precocious

NCT00094328AstraZeneca14

终止

1 期

Camostat With Bicalutamide for COVID-19Covid19SARS-CoV InfectionCoronavirus Infection

NCT04652765Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6

终止

1 期

CP-675,206 in Combination With Short Term Androgen Deprivation in Patients With Stage D0 Prostate CancerProstate Cancer

NCT00702923University of Wisconsin, Madison12

招募中

3 期

Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and AdultsSeizuresLennox Gastaut Syndrome

NCT05219617SK Life Science, Inc.252